Maxime Dely: The Human Eye – Irreplaceable Guardian of Blood Transfusion
Maxime Dely,ย Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared a post onย LinkedIn:
โThe human eye: Irreplaceable guardian of blood transfusion
In an era where artificial intelligence is revolutionizing medicine and robotization is transforming our laboratories, one field remains steadfast: visual control in blood transfusion.
Colorimetry: diagnosis at a glance
Every blood product tells a story through its color.
Turbid plasma? It’s lipemic.. A greenish tint? Trace of oral contraceptives. A pinkish coloration? Sign of hemolysis.
These instant observations guide our daily decisions.
Red blood cell concentrates reveal their quality through the coloration of the supernatant after storage. Simple, yet no machine can replace this human vigilance.
Swirling: when platelets dance
The most fascinating control? Platelet “swirling” – that whirling dance observed with the naked eye that testifies to their viability. An absent movement immediately alerts to degradation.
The leuko-platelet layer, with its creamy hue, also provides information on residual platelet quantity.
Expertise that cannot be digitized
These visual controls are essential safety barriers. Each professional develops a particular acuity, an abilty to perceivesubtle nuances.
This expertise is transmitted, refined – but cannot be robotized.
Blood transfusion illustrates the perfect balance between technology and human expertise. Automated systems optimize, IT systems trace, but it’s the trained eye that validates final quality.
Let’s value this human dimension
Behind every transfused bag lies the attentive gaze of a professional. In blood transfusion, the human eye remains our most precious safety instrument.โ
Get the latest fromย Hemostasis Today.
-
Jan 30, 2026, 11:38Aaron Rodriguez Calienes on Intracranial Stenting: Rescue vs First-Line Outcomes
-
Jan 30, 2026, 11:25Ahmed Nasreldein on Sex Disparities in Thrombolysis Delay Among Egyptian Stroke Patients
-
Jan 30, 2026, 11:17Yanki Yarman: My PhD Project Has Been Published in Blood!
-
Jan 30, 2026, 11:08Alexandros Apostolou on Complications Associated with IDU and Thrombophilia
-
Jan 30, 2026, 10:57Peisong Ma on GRK5 Polymorphism Affecting Platelets
-
Jan 30, 2026, 10:47Ashok Yadav Explains Fetal Thrombotic Vasculopathy: FTV
-
Jan 30, 2026, 10:34Saif ur Rahman Compares K2 and K3 EDTA: Key Differences Explained
-
Jan 30, 2026, 10:22Manpreet Gill on Heparin Resistance: When 14 Years of Experience Finally Gets a Plot Twist
-
Jan 30, 2026, 10:14Mohamed Elsaid on The Role of Hyperlipidemia in Thrombogenesis